Japan Veterinary Healthcare Market Introduction and Overview
According to SPER Market Research, the Japan Veterinary Healthcare Market is estimated to reach USD 4.55 billion by 2033 with a CAGR 7.07%.
The report includes an in-depth analysis of the Japan Veterinary Healthcare Market, including market size and trends, product mix, distribution channels, and supplier analysis. Veterinary healthcare refers to the medical care and services provided to animals, mostly farm animals and household pets, in order to ensure their health and well-being. It encompasses a wide range of techniques and treatments aimed at preventing, diagnosing, and treating illnesses, injuries, and various health conditions in animals. Accordingly, it requires activities to prevent illnesses and maintain the overall health of animals through vaccinations on a regular basis, control of pests, dental cleanliness, nutritional advice, and regular health assessments. In addition, veterinarians play a critical role in promoting animal rights through advocating for humane treatment, reporting abuse or neglect of animals, and defending the well-being of animals in a variety of settings.
- Japan's PETOKOTO created SOY MEAT dog food in October 2021, which is ideal for dogs who are trying to lose weight or maintain their health.
- Senju Pharmaceutical Co., Ltd., based in Osaka, introduced eye drops for cat herpesvirus infections in Japan in May 2021.
Market Opportunities and Challenges
Opportunities: The demand for veterinary treatment in Japan is being driven by the danger of zoonotic infections. The food industry and intergovernmental organizations are implementing changes to guarantee public health through immunization campaigns, research and development expenditures, and the transfer of veterinary health knowledge. Further contributing to the expansion of the Japanese veterinary healthcare market are advances in technology that have led to improvements in animal healthcare, a rise in pet ownership, and growing public awareness of the welfare of animals raised for food. Pet personification is a growing tendency in which animal caretakers show greater concern for the health and well-being of their pets, which further advances this trend. And therefore, another major growth-inducing aspect is the increased need for sophisticated veterinary facilities, preventive measures, and cutting-edge therapeutic and diagnostic methods.
Challenges: A shortage of veterinarians is increasingly impeding the veterinary healthcare business in Japan. The resistance to embracing new technologies is a major contributing factor to the scarcity of veterinarians in rural areas. Variations in the availability of raw materials and the scarcity of vaccinations against certain diseases limit the market's rate of expansion. Furthermore, it is expected that the industry will be severely limited by the increasing restrictions around antibiotics.
Market Competitive Landscape
A modest number of companies dominate the Japanese veterinary healthcare market. On the other hand, just a small number of businesses are currently entering the market and are anticipated to take a sizable portion of it. Virbac, Nisseiken Co., Ltd., Sumitomo Corporation, DS Pharma Animal Health Co., Carus Animal Health Ltd., NIHON NOHYAKU CO., LTD., and NIPPON ZENYAKU KOGYO CO., LTD. are a few of the major competitors in the market.
Scope of the Report:
Report Metric | Details |
Market size available for years | 2020-2033 |
Base year considered | 2023 |
Forecast period | 2024-2033 |
Segments covered | By Product, By Animal Type
|
Regions covered | Eastern Region, Western Region, Northern Region, Southern Region
|
Companies Covered | Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, FUJIFILM Holdings Corporation, Kyoritsu Seiyaku Corporation (Carus Animal Health), Merck & Co., Inc., NIHON NOHYAKU CO.,LTD., NIPPON ZENYAKU KOGYO CO., LTD., Nisseiken Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd, Virbac, Zoetis Inc.
|
COVID-19 Impact on Japan Veterinary Healthcare Market
The COVID-19 pandemic has affected every sector of the economy, including the veterinary healthcare sector in Japan. It is recommended that pet owners maintain a safe distance from their animals to prevent infection and to ensure cleanliness. Transporting animal goods like milk, eggs, and meat to markets has proven to be challenging. Restrictions have been put in place for seasonal border crossings involving cattle. Pet adoptions rose in the midst of the pandemic. In comparison to 2019, there was a 15% rise in dog and cat ownership, according to a 2020 Japan Pet Food Association poll.
Key Target Audience:
- Veterinarians
- Animal Owners
- Veterinary Hospitals/Clinics
- Pharmaceutical Companies
- Animal Health Product Manufacturers
- Research Institutions
- Government Agencies
- Animal Welfare Organizations
Our in-depth analysis of the Japan Veterinary Healthcare Market includes the following segments:
By Product: |
Medical And Diagnostic Equipment
Therapeutics
Diagnostics
|
By Animal Type: |
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
|
By Region: |
Eastern Region
Northern Region
Eastern Region
Western Region
|
Key Topics Covered in the Report:
- Japan Veterinary Healthcare Market Size (FY’2024-FY’2033)
- Overview of Japan Veterinary Healthcare Market
- Segmentation of Japan Veterinary Healthcare Market By Product (Therapeutics, Diagnostics)
- Segmentation of Japan Veterinary Healthcare Market By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Others)
- Expansion Analysis of Japan Veterinary Healthcare Market
- Problems and Obstacles in Japan Veterinary Healthcare Market
- Competitive Landscape in the Japan Veterinary Healthcare Market
- Impact of COVID-19 and Demonetization on Japan Veterinary Healthcare Market
- Details on Current Investment in Japan Veterinary Healthcare Market
- Competitive Analysis of Japan Veterinary Healthcare Market
- Prominent Players in the Japan Veterinary Healthcare Market
- SWOT Analysis of Japan Veterinary Healthcare Market
- Japan Veterinary Healthcare Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Japan Veterinary Healthcare Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Japan Veterinary Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Japan Veterinary Healthcare Market
7. Japan Veterinary Healthcare Market, By Product (USD Million) 2020-2033
7.1. Japan Veterinary Healthcare Market Size, Share and Forecast, By Product, 2020-2026
7.2. Japan Veterinary Healthcare Market Size, Share and Forecast, By Product, 2027-2033
7.3. Medical And Diagnostic Equipment
7.4. Therapeutics
7.4.1. Vaccines
7.4.2. Parasiticides
7.4.3. Anti-infectives
7.4.4. Medical Feed Additives
7.4.5. Others
7.5. Diagnostics
7.5.1. Immunodiagnostic Tests
7.5.2. Molecular Diagnostics
7.5.3. Diagnostic Imaging
7.5.4. Clinical Chemistry
7.5.5. Others
8. Japan Veterinary Healthcare Market, By Animal Type (USD Million) 2020-2033
8.1. Japan Veterinary Healthcare Market Size, Share and Forecast, By Animal Type, 2020-2026
8.2. Japan Veterinary Healthcare Market Size, Share and Forecast, By Animal Type, 2027-2033
8.3. Dogs and Cats
8.4. Horses
8.5. Ruminants
8.6. Swine
8.7. Poultry
8.8. Others
9. Japan Veterinary Healthcare Market Forecast, 2020-2033 (USD Million)
9.1. Japan Veterinary Healthcare Market Size and Market Share
10. Japan Veterinary Healthcare Market, By Region, 2020-2033 (USD Million)
10.1. Japan Veterinary Healthcare Market Size and Market Share By Region (2020-2026)
10.2. Japan Veterinary Healthcare Market Size and Market Share By Region (2027-2033)
10.3. Eastern Region
10.4. Northern Region
10.5. Eastern Region
10.6. Western Region
11. Company Profile
11.1. Boehringer Ingelheim GmbH
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Elanco Animal Health Incorporated
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. FUJIFILM Holdings Corporation
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Kyoritsu Seiyaku Corporation (Carus Animal Health)
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Merck & Co., Inc.
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. NIHON NOHYAKU CO.,LTD.
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. NIPPON ZENYAKU KOGYO CO., LTD.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Nisseiken Co., Ltd.
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Sumitomo Dainippon Pharma Co., Ltd
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Virbac
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Zoetis Inc.
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Others
12. Conclusion
13. Reference Links
14. List of Abbreviations